Great Point Partners’s Relmada Therapeutics RLMD Stock Holding History

Great Point Partners’s Portfolio RLMD Stock Details RLMD Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.86M	Buy
2022 Q4	–	Sell
2022 Q3	$18.9M	Sell
2022 Q2	$13.3M	Sell
2022 Q1	$21.3M	Buy
2021 Q4	$16.2M	Buy